'This isn't what mine looked like': A qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Walter, Fiona M ^a,b   Birt, Linda ^a   Cavers, Debbie ^c   Scott, Suzanne ^d   Emery, Jon ^a,b   Burrows, Nigel ^e   Cavanagh, Gina ^f   MacKie, Rona ^g   Weller, David ^c   Campbell, Christine ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BLEEDING; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL FEATURE; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; CUTANEOUS MELANOMA; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FAMILY; FEMALE; FRIEND; HEALTH BELIEF; HEALTH CARE PERSONNEL; HELP SEEKING BEHAVIOR; HISTOPATHOLOGY; HUMAN; LENTIGO MALIGNA MELANOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA SKIN CANCER; MULTICENTER STUDY; PATIENT MONITORING; PRURITUS; QUALITATIVE RESEARCH; REASSURANCE; RISK FACTOR; SKIN; STRUCTURED INTERVIEW; SYMPTOM; TUMOR VOLUME; INTERVIEW; MELANOMA; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SELF EVALUATION; SKIN TUMOR; SYMPTOM ASSESSMENT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC SELF EVALUATION; FEMALE; HELP-SEEKING BEHAVIOR; HUMANS; INTERVIEWS AS TOPIC; MALE; MELANOMA; MIDDLE AGED; QUALITATIVE RESEARCH; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SYMPTOM ASSESSMENT;

EID: 84904655975     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005566     Document Type: Article

References (36)

1. Abdel-Rahman M, Stockton D, Rachet B, et al. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009;101(Suppl 2):S115-24.
2. Cancer Research UK. http://www.cancerresearchuk.org/cancerinfo/ cancerstats/types/skin/survival/#stage (accessed 8 Jun 2014).
3. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004;40:2355-66.
4. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83. (Pubitemid 47321600)
5. Jemal A, Devesa SS, Hartge P, et al. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001;93:678-83. (Pubitemid 32492808)
6. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009;27:3-9.
7. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199-206.
8. Farasat S, Yu SS, Neel VA, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64:1051-9.
9. Martorell-Calatayud A, Nagore E, Botella-Estrada R, et al. Defining fast-growing melanomas: reappraisal of epidemiological, clinical, and histological features. Melanoma Res 2011;21:131-8.
10. Lyratzopoulos G, Abel GA, McPhail S, et al. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer 2013;108:686-90.
11. Baughan P, O'Neill B, Fletcher E. Auditing the diagnosis of cancer in primary care: the experience in Scotland. Br J Cancer 2009;101(Suppl 2):S87-91.
12. Keeble S, Abel GA, Saunders CL, et al . Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a national audit of cancer diagnosis in primary care. Int J Cancer 2014;135:1220-8.
13. Austoker J, Bankhead C, Forbes LJ, et al. Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer 2009;101(Suppl 2):S31-9.
14. Branstrom R, Hedblad MA, Krakau I, et al. Reasons to seek medical attention for a skin check-up: the layman's perspective. Eur J Public Health 2003;13:294-8. (Pubitemid 38063578)
15. Walter FM, Humphrys E, Tso S, et al. Patient understanding of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study. BMC Fam Pract 2010;11:62.
16. Emery JD, Walter FM, Gray V, et al. Diagnosing cancer in the bush: a mixed-methods study of symptom appraisal and help-seeking behaviour in people with cancer from rural Western Australia. Fam Pract 2013;30:294-301.
17. Walter FM, Webster A, Scott S, et al. The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy 2012;17:110-18.
18. Scott SE, Walter FM, Webster A, et al. The model of pathways to treatment: conceptualization and integration with existing theory. Br J Health Psychol 2013;18:45-65.
19. Glasner T, van der Vaart W. Applications of calendar instruments in social surveys: a review. Qual Quant 2009;43:333-49.
20. Fitzpatrick TB, Sober AJ. Sunlight and skin cancer. N Engl J Med 1985;313:818-20. (Pubitemid 15232319)
21. Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 2013;13:117.
22. Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012;106:1262-7.
23. Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 2011;11:284.
24. Mackie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermat 1991;16:151-3.
25. Grob JJ, Bonerandi JJ. The 'ugly duckling' sign: identification of the common characteristics of naevi in an individual as a basis for melanoma screening. Arch Dermatol 1998;134:103-4. (Pubitemid 28087124)
26. Cancer research UK. About be clear on cancer. 2013. http://www. cancerresearchuk.org/cancerinfo/spotcancerearly/naedi/beclearoncancer/ background (accessed 8 Jun 2014).
27. Nyawata I, Topping A. Symptom interpretation as a source of delay in malignant melanoma presentation - a literature review. Clin Effect Nurs 2006;9:e68-78.
28. Topping A, Nkosana-Nyawata I, Heyman B. 'I am not someone who gets skin cancer': risk, time and malignant melanoma. Health Risk Soc 2013;15(6-7):596- 614.
29. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000;89:271-9. (Pubitemid 30430744)
30. Baade PD, English DR, Youl PH, et al. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol 2006;142:1422-7. (Pubitemid 44790635)
31. Simon AE, Waller J, Robb K, et al. Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomarkers Prev 2010;19:2272-7.
32. Forbes LJ, Simon AE, Warburton F, et al. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK: do they contribute to differences in cancer survival? Br J Cancer 2013;108:292-300.
33. Aldridge RB, Zanotto M, Ballerini L, et al. Novice identification of melanoma: not quite as straightforward as the ABCDs. Acta DermatoVenereol 2011;91:125-30.
34. Mitchell E, Rubin G, Macleod U. Improving diagnosis of cancer - a toolkit for General Practice. Royal College of General Practitioners, 2012.
35. Tyagi A, Miller K, Cockburn M. e-Health Tools for targeting and improving melanoma screening: a review. J Skin Cancer 2012;2012:437502.
36. Mackie R. Malignant melanoma. A guide to early diagnosis. Glasgow: University Department of Dermatology, 1989.